Tavanta Therapeutics, headquartered in Media, is currently undergoing a reorganization from Druggability Technologies Holdings Ltd located in Hungary.
The company handles special pharmaceuticals and is looking to continue its success in the commercialization and development of novel specialty drugs. Companies such as this one often turn to printing services to inform patients, customers, and others in the industry of such reorganizations.
Lynne Powell, Chief Executive Officer of Tavanta Therapeutics, said that it is critical for the company to complete this reorganization so that it can maintain its sustained growth in the United States. Powell added that the leadership team is a high-quality and diverse one with each member having great depth and breadth of experience, and that the company is looking forward to developing new pharmaceuticals for its patients and creating value for stakeholders.
The company attributes its success to developing strategic partnerships early in the process of identifying drug candidates by using its own internally developed pipelines and licensing of drug targets. It also looks to interested parties for making inquiries, and for collaborative relationships for the commercialization and development of clinical candidates.
In a press release, the company says its name refers to its commitment to advancing therapeutics to those who medical needs have not been met, in order to improve their lives. It embraces a vibrant, values-based culture.
Location
100 Ridge Road
Suite 39
Chadds Ford, PA 19317
Get Directions →
Phone
Hours
Mon: 9:00 - 5:00
Tue: 9:00 - 5:00
Wed: 9:00 - 5:00
Thu: 9:00 - 5:00
Fri: 9:00 - 5:00
Sat: Closed
Sun: Closed